FDA aspirin label warning
Executive Summary
July 5 agency press release announcing new aspirin labeling language included an important typo in warning against use of aspirin in the third trimester of pregnancy. FDA said the use "may cause problems in the newborn child." The correct warning should say "may cause problems in the unborn child".